Naoyoshi Maeda

1.5k total citations
40 papers, 1.3k citations indexed

About

Naoyoshi Maeda is a scholar working on Immunology, Small Animals and Epidemiology. According to data from OpenAlex, Naoyoshi Maeda has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 11 papers in Small Animals and 11 papers in Epidemiology. Recurrent topics in Naoyoshi Maeda's work include Infectious Diseases and Mycology (11 papers), T-cell and Retrovirus Studies (10 papers) and Myxozoan Parasites in Aquatic Species (8 papers). Naoyoshi Maeda is often cited by papers focused on Infectious Diseases and Mycology (11 papers), T-cell and Retrovirus Studies (10 papers) and Myxozoan Parasites in Aquatic Species (8 papers). Naoyoshi Maeda collaborates with scholars based in Japan, United States and Spain. Naoyoshi Maeda's co-authors include Hung Fan, Yasunobu Yoshikai, Massimo Palmarini, Claudio Murgia, Risa Nakamura, Tetsuo Kase, Hisakata Yamada, Kensuke Shibata, Yoshitaka Hirose and Shinji Murosaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Naoyoshi Maeda

40 papers receiving 1.2k citations

Peers

Naoyoshi Maeda
Susan T. Howard United States
J. Muse Davis United States
Jieh‐Juen Yu United States
P Foxall United States
Chiung-Yu Hung United States
Marcel Wüthrich United States
Mara Gerloni United States
Susan T. Howard United States
Naoyoshi Maeda
Citations per year, relative to Naoyoshi Maeda Naoyoshi Maeda (= 1×) peers Susan T. Howard

Countries citing papers authored by Naoyoshi Maeda

Since Specialization
Citations

This map shows the geographic impact of Naoyoshi Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoyoshi Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoyoshi Maeda more than expected).

Fields of papers citing papers by Naoyoshi Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoyoshi Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoyoshi Maeda. The network helps show where Naoyoshi Maeda may publish in the future.

Co-authorship network of co-authors of Naoyoshi Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Naoyoshi Maeda. A scholar is included among the top collaborators of Naoyoshi Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoyoshi Maeda. Naoyoshi Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maeda, Naoyoshi, et al.. (2020). Antitumor Effect of Sugar-Modified Cytosine Nucleosides on Growth of Adult T-Cell Leukemia Cells in Mice. Vaccines. 8(4). 658–658. 1 indexed citations
2.
Maeda, Naoyoshi, Yasuo Inoshima, M. De las Heras, & Katsumi Maenaka. (2020). Enzootic nasal tumor virus type 2 envelope of goats acts as a retroviral oncogene in cell transformation. Virus Genes. 57(1). 50–59. 3 indexed citations
3.
Furukawa, Atsushi, Tomoki Yamada, Naoyoshi Maeda, et al.. (2017). Structural and thermodynamic analyses reveal critical features of glycopeptide recognition by the human PILRα immune cell receptor. Journal of Biological Chemistry. 292(51). 21128–21136. 9 indexed citations
4.
Maeda, Naoyoshi, et al.. (2017). Therapeutic application of human leukocyte antigen-G1 improves atopic dermatitis-like skin lesions in mice. International Immunopharmacology. 50. 202–207. 7 indexed citations
5.
Maeda, Naoyoshi, Takashi Ohashi, Haorile Chagan‐Yasutan, et al.. (2015). Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia. Retrovirology. 12(1). 99–99. 21 indexed citations
6.
Iwai, Atsushi, Koji Kawata, Daisuke Muramatsu, et al.. (2015). Oral administration of the Aureobasidium pullulans-derived β-glucan effectively prevents the development of high fat diet-induced fatty liver in mice. Scientific Reports. 5(1). 10457–10457. 24 indexed citations
7.
Kanayama, Masashi, Yutaka Matsui, Koyu Ito, et al.. (2014). Tumor-α9β1 integrin-mediated signaling induces breast cancer growth and lymphatic metastasis via the recruitment of cancer-associated fibroblasts. Journal of Molecular Medicine. 92(12). 1271–1281. 21 indexed citations
8.
Nakamura, Risa, Hisakata Yamada, Kensuke Shibata, et al.. (2014). Type I Interferon Plays Opposing Roles in Cytotoxicity and Interferon-&#947; Production by Natural Killer and CD8<sup>+</sup> T Cells after Influenza A Virus Infection in Mice. Journal of Innate Immunity. 6(4). 456–466. 13 indexed citations
9.
Alhoshani, Ali, Naoyoshi Maeda, Saskia Milton, et al.. (2012). The Oncogenic Jaagsiekte Sheep Retrovirus Cytoplasmic Tail Adopts a Unique Conformation on a Phosphocholine Surface. Biophysical Journal. 102(3). 267a–268a. 1 indexed citations
10.
Maeda, Naoyoshi. (2010). Swine-origin influenza-virus-induced acute lung injury: Novel or classical pathogenesis?. World Journal of Biological Chemistry. 1(5). 85–85. 7 indexed citations
11.
Maeda, Naoyoshi, Hiromi Muta, Ezogelin Oflazoglu, & Yasunobu Yoshikai. (2009). Susceptibility of human T‐cell leukemia virus type I‐infected cells to humanized anti‐CD30 monoclonal antibodies in vitro and in vivo. Cancer Science. 101(1). 224–230. 16 indexed citations
12.
Maeda, Naoyoshi, Risa Nakamura, Yoshitaka Hirose, et al.. (2009). Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. International Immunopharmacology. 9(9). 1122–1125. 148 indexed citations
14.
Maeda, Naoyoshi, Hung Fan, & Yasunobu Yoshikai. (2008). Oncogenesis by retroviruses: old and new paradigms. Reviews in Medical Virology. 18(6). 387–405. 53 indexed citations
15.
Cousens, Chris, Naoyoshi Maeda, Claudio Murgia, et al.. (2007). In vivo tumorigenesis by Jaagsiekte sheep retrovirus (JSRV) requires Y590 in Env TM, but not full-length orfX open reading frame. Virology. 367(2). 413–421. 31 indexed citations
16.
Maeda, Naoyoshi & Yasunobu Yoshikai. (2007). New molecular mechanisms of virus-mediated carcinogenesis: oncogenic transformation of cells by retroviral structural protein Envelope. Uirusu. 57(2). 159–170. 2 indexed citations
17.
Hallwirth, Claus V., Naoyoshi Maeda, Denis York, & Hung Fan. (2005). Variable Regions 1 and 2 (VR1 and VR2) in JSRV gag Are Not Responsible for the Endogenous JSRV Particle Release Defect. Virus Genes. 30(1). 59–68. 8 indexed citations
18.
Maeda, Naoyoshi, Yoshio Koyanagi, Naoko Misawa, et al.. (1999). Acquisition of HIV Type 1 Resistance by beta-Chemokine-Producing CD4 + T Cells. AIDS Research and Human Retroviruses. 15(16). 1453–1460. 5 indexed citations
19.
Ikematsu, Hideyuki, Akira Nabeshima, Shigeki Nabeshima, et al.. (1999). Evaluation of a Rapid Enzyme Immunoassay for Detection of Influenza A Virus among Adult and Elderly Patients. Kansenshogaku zasshi. 73(11). 1153–1158. 1 indexed citations
20.
Maeda, Naoyoshi, T. Kawamura, Hiroo Hoshino, et al.. (1998). Inhibition of Human T-Cell Leukemia Virus Type 1 Replication by AntisenseenvOligodeoxynucleotide. Biochemical and Biophysical Research Communications. 243(1). 109–112. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026